ストックスクリーナーアプリを入手
21.19
3.11%
0.64
前日終値:
$20.55
開ける：
$20.59
24時間の取引高:
342.58K
Relative Volume:
3.26
時価総額：
$736.33M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+5.69%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$20.00
$22.20
1週間の範囲:
$19.65
$25.58
52週間の値動き範囲:
$16.59
$25.58
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Compare TRAX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
21.19 | 736.33M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | 開始されました | Leerink Partners | Outperform |
| 2026-04-24 | 開始されました | Wedbush | Outperform |
| 2026-04-23 | 開始されました | JP Morgan | Overweight |
| 2026-04-22 | 開始されました | Barclays | Overweight |
| 2026-04-21 | 開始されました | UBS | Buy |
First Tracks Biotherapeutics Inc (TRAX) 最新ニュース
First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long (TRAX) - Seeking Alpha
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Sahm
First Tracks Price Target Announced at $54.00/Share by Piper Sandler - Moomoo
First Tracks Initiated at Overweight by Piper Sandler - Moomoo
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations F - Benzinga
Piper Sandler initiates First Tracks stock with overweight rating By Investing.com - Investing.com Nigeria
Net income of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga
TRAX Price History for First Tracks Biotherapeutics Stock - Barchart
Number of employees of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
What is the current Price Target and Forecast for First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Earnings Yield (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Assets (Quarterly) - Zacks Investment Research
H.C. Wainwright Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $30 - Moomoo
First Tracks Biotherapeutics, Inc. (TRAX) Price To Cash Flow - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Long Term Debt (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Price To Free Cash Flow - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Net Income (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash Equivalents (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Liabilities - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Eps Diluted - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Book Value - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Shareholders Equity (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Investing (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Enterprise Value - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Gross Profit (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Gross Margin (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Operations (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Market Cap - Zacks Investment Research
This Micron Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
HC Wainwright Initiates First Tracks Biotherapeutics at Buy - marketscreener.com
H.C. Wainwright initiates First Tracks stock with buy rating By Investing.com - Investing.com Canada
AnaptysBio Completes Spin-Off of First Tracks Biotherapeutics: Key Financial Impacts and Pro Forma Results - Minichart
First Tracks Biotherapeutics, Inc. Financial Statements – NASDAQ:TRAX - TradingView
Price to earnings ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Statistics – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Anaptysbio’s spinout First Tracks hits the slopes - BioWorld News
AnaptysBio rises after completing First Tracks spinoff - MSN
Leerink Partners Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $46 - Moomoo
First Tracks Biotherapeutics, Inc. Dividends – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Income Statement – NASDAQ:TRAX - TradingView
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc (TRAX) 財務データ
First Tracks Biotherapeutics Inc (TRAX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):